Results 201 to 210 of about 1,040,831 (304)
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen +9 more
wiley +1 more source
Dynamic simulation study on gas flooding mechanism based on level set method at the micro-nano scale. [PDF]
Yu Y +5 more
europepmc +1 more source
Neutral aldoses as source indicators for marine snow [PDF]
Alldredge, A. +4 more
core +1 more source
Translational cancer research and its implementation through competitively selected Comprehensive Cancer Centers across Europe should be the primary policy focus for addressing the increasing cancer burden in Europe and counteract the present main strategy to convert cancer to a chronic disease.
Manuel Heitor +2 more
wiley +1 more source
Intrinsic Hydrogen-Deuterium Exchange Rates in H<sub>2</sub>O/D<sub>2</sub>O Mixtures. [PDF]
Grimaldi A, Stofella M, Paci E.
europepmc +1 more source
Photoselective isotope fractionation dynamics in cosmo and atmospheric chemistry [PDF]
R. D. Levine
openalex +1 more source
Insights into a long life without cancer: The case of the bowhead whale
Long‐lived, large‐bodied organisms have evolved powerful anticancer mechanisms that preserve cellular and tissue integrity across extended lifespans. A recent study by Firsanov et al. shows that greater genome stability is a key factor underlying the remarkable longevity and cancer resistance of one such species, the bowhead whale.
Inés Paniagua, Johanna A. Joyce
wiley +1 more source
Making Carbon-Fiber Reinforced Epoxy-Amine Thermoset Composites More Circular through Chemical Recycling by Catalyzed Solvolysis. [PDF]
De Fabritiis V +3 more
europepmc +1 more source
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata +10 more
wiley +1 more source

